| Literature DB >> 31280962 |
Justin G English1, Reid H J Olsen2, Katherine Lansu2, Michael Patel3, Karoline White4, Adam S Cockrell5, Darshan Singh2, Ryan T Strachan2, Daniel Wacker2, Bryan L Roth6.
Abstract
Directed evolution, artificial selection toward designed objectives, is routinely used to develop new molecular tools and therapeutics. Successful directed molecular evolution campaigns repeatedly test diverse sequences with a designed selective pressure. Unicellular organisms and their viral pathogens are exceptional for this purpose and have been used for decades. However, many desirable targets of directed evolution perform poorly or unnaturally in unicellular backgrounds. Here, we present a system for facile directed evolution in mammalian cells. Using the RNA alphavirus Sindbis as a vector for heredity and diversity, we achieved 24-h selection cycles surpassing 10-3 mutations per base. Selection is achieved through genetically actuated sequences internal to the host cell, thus the system's name: viral evolution of genetically actuating sequences, or "VEGAS." Using VEGAS, we evolve transcription factors, GPCRs, and allosteric nanobodies toward functional signaling endpoints each in less than 1 weeks' time.Entities:
Keywords: G-protein coupled receptors; GPCR; artificial selection; mammalian-directed evolution; molecular pharmacology; nanobodies; transcription factors; viral engineering
Mesh:
Substances:
Year: 2019 PMID: 31280962 PMCID: PMC6660416 DOI: 10.1016/j.cell.2019.05.051
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582